Case Tech Ventures
10900 Euclid Avenue, Cleveland, Ohio, 44106-7026, United States
Overview
Case Technology Ventures (CTV) is the pre-seed venture capital and technology validation fund at Case Western Reserve University. CTV focuses on creating new companies for the Northeast Ohio region by providing capital to pre-seed stage companies based on intellectual property developed at Case and its affiliate institutions. The fund was launched in November 2002 and invests across technological boundaries. Financial support for CTV comes from Case Western Reserve University and the State of Ohio's Third Frontier Project.
- Total investments
- 2
- Lead investments
- 1
- Investments · 12mo
- 0
- Active investors
- 0
Sector focus
- Finance
Investment portfolio
- Neuros Medical
Participated · Equity · Jul 2012
Neuros Medical is a Willoughby Hills, Ohio–based neuromodulation company focused on treating intractable post-amputation pain through its proprietary Altius High-Frequency Nerve Block system. The implant consists of a cuff electrode placed around a peripheral nerve and an implantable pulse generator that delivers high-frequency electrical signals to block pain transmission. The technology, originally invented at Case Western Reserve University by Drs. Kevin Kilgore and Niloy Bhadra, targets both phantom limb pain and residual limb pain. Neuros Medical is currently running the pivotal QUEST trial, a 180-subject, randomized, double-blinded, active-sham–controlled study being conducted under an IDE to evaluate safety and effectiveness. Proceeds from the latest financing will fund completion of QUEST enrollment and preparation of a Pre-Market Approval application to the FDA. Led by President and CEO Tom Wilder, the company aims to commercialize Altius as a novel alternative to existing pain management solutions. Financial metrics such as revenue or installed base were not disclosed in the article.
Team
No current team members are available.